Baxter Aktiengesellschaft

Industry / private company


Location: Wien, Austria (AT) AT

ISNI: 000000449113591

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. (2020) Weidner L, Gaensdorfer S, Unterweger S, Weseslindtner L, Drexler C, Farcet M, Witt V, et al. Journal article Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies (2016) Borte M, Krivan G, Derfalvi B, Marodi L, Harrer T, Jolles S, Bourgeois C, et al. Journal article Engineering axially vascularized bone in the sheep arteriovenous-loop model (2013) Boos A, Loew JS, Weigand A, Deschler G, Klumpp D, Arkudas A, Bleiziffer O, et al. Journal article Composition of fibrin glues significantly influences axial vascularization and degradation in isolation chamber model (2012) Arkudas A, Pryymachuk G, Höreth T, Beier J, Polykandriotis E, Bleiziffer O, Gulle H, et al. Journal article Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model (2011) Boos A, Loew JS, Deschler G, Arkudas A, Bleiziffer O, Gulle H, Dragu A, et al. Journal article Automatic quantitative micro-computed tomography evaluation of angiogenesis in an axially vascularized tissue-engineered bone construct (2010) Arkudas A, Beier J, Pryymachuk G, Höreth T, Bleiziffer O, Polykandriotis E, Heß A, et al. Journal article